Dover, DE, United States of America

Abgenomics International Inc.


USPTO Granted Patents = 5

% Expired Patents = 40.0


Trademarks = 1

Forward Citations = 75

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Shih-Yao Lin (5 out of 26 patents)

silverMedal Rong-Hwa Lin (5 out of 20 patents)

bronzeMedal Chiu-Chen Huang (4 out of 12 patents)

4.  Yu-Chi Hsieh (4 out of 5 patents)

5.  Yu-Ying Tsai (2 out of 7 patents)

6.  Shu-Hua Lee (1 out of 4 patents)

7.  Feng-Lin Chiang (1 out of 2 patents)

8.  Li-An Hu (1 out of 1 patent)


5 patents:

Company Overview
Abgenomics International Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing novel antibody-based therapies for autoimmune diseases and cancer. With a strong emphasis on cutting-edge research, Abgenomics aims to provide innovative solutions for patients in need of effective treatments. Their dedication to precision medicine and personalized healthcare drives their pursuit of groundbreaking therapies that hold the potential to transform patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#90 in Dover, DE

#732 in Delaware

#51,570 in US

Dover, DE (US)
Dover, DE, United States of America
Forward Citations = 75

8 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Abgenomics International Inc.. Retrieved from https://idiyas.com/company/abgenomics-international

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…